| Nazwa produktu | Fasoracetam |
| Numer CAS | 110958-19-5 |
| Wzór cząsteczkowy | C10H16N2O2 |
| Masa cząsteczkowa | 212.25 g/mol |
| Wygląd | Biały lub prawie biały krystaliczny proszek |
| Oznaczenie (HPLC) | ≥ 99,01 TP3T |
| Temperatura topnienia | 118–122°C |
| Strata przy suszeniu | ≤ 0,5% |
| Popiół po spaleniu | ≤ 0,11 TP3T |
| Metale ciężkie | ≤ 10 ppm |
Potrzebujesz pomocy? Skontaktuj się z naszym zespołem
Fasoracetam (also known as NS-105) is a potent nootropic compound belonging to the racetam family. Unlike many other racetams that primarily target memory enhancement, fasoracetam is known for its anxiolytic (anti-anxiety) oraz focus-enhancing properties, combined with cognitive support.
Fasoracetam is one of the few racetams that acts as a GABA-B receptor antagonist. This unique mechanism reduces anxiety and improves focus without sedation—unlike traditional anxiolytics (benzodiazepines) which cause drowsiness.
Fasoracetam | NS-105
Fasoracetam was developed in the early 1990s. Scientists from the Japanese pharmaceutical company Nippon Shinyaku. They were looking for an effective remedy that could be used in treatments for Alzheimer’s disease. However, further studies have shown that it is a preparation that can also be successfully used in the treatment of ADHD or dementia, as well as improving memory and cognitive abilities in healthy people.
Racetam Family Comparison:
| Związek | Primary Mechanism | Anxiolytic Effect | Focus Effect | Memory Effect |
|---|---|---|---|---|
| Fasoracetam | GABA-B antagonist | Strong | Strong | Moderate |
| Piracetam | AMPA modulation | Minimal | Mild | Moderate |
| Aniracetam | AMPA + GABA-A | Moderate | Mild | Strong |
| Pramiracetam | HACU enhancement | Minimal | Mild | Very Strong |
| fenylopiracetam | AMPA + dopamine | Mild | Strong | Moderate |
Synonim: NS-105
Most racetams work through AMPA/glutamate pathways. Fasoracetam’s GABA-B antagonism is unique among nootropics. By blocking inhibitory GABA-B receptors, it reduces excessive neural inhibition—improving focus and reducing anxiety without the sedation of benzodiazepines.
📧 Zapytania: info@lyvbio.com
LyvBio Sp. z o.o. is a supplier of high-purity Fasoracetam for the nutraceutical and nootropic industries.
Możliwości dostawcze:
Czystość: ≥99,01 TP3T (HPLC)
Miesięczna wydajność: 200+ kg
Duże ilości: 100 g – 5 000 kg
Czas realizacji: 3–5 dni (próbki), 10–15 dni (towar luzem)
Dokumentacja: COA, HNMr, HPLC chromatogram, stability data
| Składnik | Primary Benefit | Synergy with Fasoracetam |
|---|---|---|
| Aniracetam | Memory + anxiolytic (GABA-A) | Complementary GABA-A + GABA-B modulation |
| Noopept | AMPA, BDNF, neuroprotection | Focus + neuroprotection |
| fenylopiracetam | Stimulation + cognitive | Calm focus + stimulation |
| L-teanina | Calm focus (GABA-A, AMPA) | Balanced GABA modulation |
| Alpha-GPC | Choline source | Cognitive performance |
| Ashwagandha | Adaptogen, stress reduction | Stress + focus |
| Piracetam | AMPA modulation | Broad cognitive enhancement |
| Pramiracetam | Potent memory support | Memory + focus |
All technical inquiries receive a response within 24 hours, including COA, HNMr, HPLC chromatogram, pricing, and formulation recommendations.
📧 E-mail: info@lyvbio.com
🌐 Strona internetowa: https://www.lyvbio.com
English English 
Russian
French
Korean
German
Polish
Japanese
Spanish
Italian
Vietnamese